Hana Krismawati
Jakarta, JK, Indonesia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Fear of clofazimine-induced skin discoloration as a barrier to leprosy treatment: urgent need for alternative therapeutic options.
Journal: Clinical and experimental dermatology
Published: June 04, 2026
Evaluating the risk of dapsone hypersensitivity syndrome in Nepalese Leprosy Patients via HLA-B* 13:01 screening using real-time PCR and comparative meta-analysis of international data.
Journal: PLoS neglected tropical diseases
Published: January 09, 2026
Seroprevalence of Mycobacterium leprae antibodies among school children in Indonesia in 2023: a cross-sectional study.
Journal: The Lancet regional health. Southeast Asia
Published: July 18, 2025
Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs.
Journal: The Lancet regional health. Southeast Asia
Published: November 03, 2024
Changing the narrative: visual methods can reinforce or reduce disease-related stigma.
Journal: BMJ global health
Published: June 11, 2024
Metformin as adjunctive therapy in combination with multidrug treatment for multibacillary leprosy: A protocol for a randomized double-blind, controlled Phase 2 trial in Indonesia (MetLep Trial).
Journal: Wellcome open research
Published: April 25, 2024
Leprosy identified in Sumba Island, eastern Indonesia: elimination targets under threat.
Journal: The Lancet regional health. Southeast Asia
Published: December 14, 2023
The unbreakable journey: using photovoice to raise awareness and fight leprosy stigma in Papua, Indonesia.
Journal: The British journal of dermatology
Published: December 13, 2022
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
Journal: PLoS neglected tropical diseases
Published: May 01, 2020
Last Updated: 09/26/2026